Applications published 16 May 2007
Improved topical skin care compsns
Avon Products 1781158*
Controlled release formulations of enzymes, micro-organisms and antibodies with mucoadhesive polymers
Amano Enzyme 1784160*
Controlled-release formulation comprising tamsulosin hydrochloride
Instytut Farmaceutyczny 1784161*
System and method for modifying a fluid for oral administration
Remote Clinical Solutions 1784162*
Nano-emulsion, the use thereof and preparation method thereof
Kim, Young Dae; Park, Jung Soo; Kim, Ji Soo; Kim, Ji Soo 1784163*
Methods for transmembrane treatment and prevention of otitis media
Piedmont Pharmaceutica 1784164*
Stable particle formulations of erythropoietin receptor agonists
Alza 1784165*
Compsns comprising 5-amino-2-hydroxybenzoic acid and a reducing sugar
Procter & Gamble 1784166*
Multi-layer tablets and bioadhesive dosage forms
Spherics 1784167*
Method of use of herbal compsns
Medigreen Biotechnology 1784168*
Polymeric adhesive matrix with salified carboxylic groups for transdermal use
Bouty 1748169*
Atrium patch
Labtec Gesellschaft fuer Technologische Forschung und Entwicklung 1784170*
Topical otic compsns and methods of topical treatment or prevention of otic infections
Insite Vision 1784171*
Cancer chemotherapy
Hutchison Medipharma Enterprises 1784172*
Pharmaceutical compsn for preventing and treating metabolic diseases containing alpha-arylmethoxyacrylate derivatives
Korea Research Institute of Chemical Technology; Oscotec 1784173*
A pharmaceutical compsn comprising gabapentin
Zambon 1784174*
Inhibitors of AKT activity
Merck 1784175*
Compsn comprising lactic acid and lactoferrin
Nastor Medical 1784176*
Novel formulation for L-tryptophane comprising cabidopa/benserazide
Dr Kamprad 1784177*
Aryl (or heteroaryl) azolylcarbinols
Laboratoires del Dr Esteve 1784178*
Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
Merck 1784179*
2-amino 1H imidazo ring systems and methods
3M Innovative Properties 1784180*
VEGF inhibition
Newsouth Innovations Pty Ltd 1784181*
2-sulphanyl-benzimidazol-1-yl-acetic acid derivatives as CRTH2 antagonists
Actelion Pharmaceuticals 1784182*
Processes for the preparation of isothiazole derivatives
Pfizer Products 1784183*
The use of N-aryl diazaspiracyclic compounds in the treatment of addiction
Targacept 1784184*
Chemical compounds
SmithKline Beecham 1784185*
Methods for treating or preventing erectile dysfunction or urinary incontinence
Inotek Pharmaceuticals 1784186*
Androgen receptor modulators
Merck 1784187*
Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
Merck 1784188*
Modulators of HCV replication
Istituto di Ricerche di Biologia Molecolate P Angeletti 1784189*
Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
Prometic Biosciences 1784190*
Treatment of psychological and cognitive disorders using a cholesterol-lowering agent in combination with an antidepressant
The McLean Hospital Corp 1784191*
Vaginal cream compsns, kits thereof and methods of using thereof
Duramed Pharmaceuticals; Ahmed, Salah; Ben-Maimon, Carole; Hait, Howard 1784192*
Compsn and method for treatment and prevention of atherosclerosis
Howard J Smith 1784193*
Histone deacetylase inhibitors
Merck; Aton Pharma 1784194*
Pharmaceutical compsn comprising galactose, selenium, vitamin E and/or phosphatidyl choline, and pharmaceutical uses of galactose
Mosetter, Kurt 1784195*
Ceramide derivatives as modulators of immunity and autoimmunity
Albert Einstein College of Medicine of Yeshiva University 1784196*
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulphate for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis
EpiGenesis Pharmaceuticals 1784197*
Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases
Redox Pharmaceutical Corp Audubon Biomedica 1784198*
Compounds for the treatment of marijuana dependence, withdrawal, and usage
McLean Hospital Corp 1784199*
Method and compsn for modulation of systemic inflammatory responses syndrome (SIRS)
Medical Research Fund at the Tel Aviv Sourasky Medical Center 1784200*
Physiologically active compsn
Cargill 1784201*
Method of treating, preventing, inhibiting or reducing damage to cardiac tissue
The University of Texas Southwestern Medical Centre at Dallas; Regenerx Biopharmaceuticals 1784204*
Stretch mark treatment with botulinum toxin
Allergan 1784205*
Antimicrobial peptides derived from CAP18
OctoPlus Sciences; Academische Ziekenhuis Leiden 1784206*
ICA512 couples insulin secretin and gene expression in beta cells
Technische Universitaet Dresden Medizinische Fakultaet Carl Gustav Carus 1784207*
Use of a DNA molecule as vaccine adjuvant
Forinnova 1784208*
Contraceptives based on SP22 and SP22 antibodies
US Environmental Protection Agency 1784209*
Carrier conjugates of GNRH-peptides
Cytos Biotechnology 1784210*
Immunogenic compsns for gram positive bacteria such as streptococcus agalactiae
Novartis Vaccines and Diagnostics 1784211*
Polypeptides for inducing a protective immune response against Staphylococcus aureus
Merck 1784212*
Improvements relating to meningococcal outer membrane vesicles
Novartis Vaccines and Diagnostics 1784213*
Multivalent meningococcal derivatised polysaccharide-protein conjugates and vaccine
Sanofi Pasteur 1784214*
1,4 O-linked saccharose derivatives for stabilising antibodies or antibody derivatives
Boehringer Ingelheim Pharma 1784215*
S100 protein inhibitors for treating leukemia
Universite Laval 1784216*
Treatment of HIV infection by T-cell modulation
Bayer Schering Pharma Aktiengesellschaft 1784217*
Nutritional compsn comprising immunoglobulins and oligosaccharides
Nutricia 1784218*
Stabilising formulations
Wyeth 1784219*
Bacterial iron acquisition targets
The University of Western Ontario 1784220*
Method for the treatment and prevention of infection using anti-selectin agents
Ligocyte Pharmaceuticals; Montana State University; Montana Hall 1784221*
Nutritional compsn comprising indigestible oligosaccharides
NV Nutricia 1784222*
Compsn comprising plant and/or fish oils and non-oxidisable fatty acid entities
Thia Medica 1784223*
EGFR kinase inhibitor combinations for treating respiratory and gastrointestinal disorders
Boehringer Ingelheim International 1784224*
Biomimetic of Evodia rutaecarpa fruit extract for amelioration of inflammation
Applied Genetics Incorporated Dermatics 1784225*
Cyanine dyes conjugated with antibodies for the diagnosis of micrometastasis
Bayer Schering Pharma Aktiengesellschaft 1784226*